Patent: 9,441,047
✉ Email this page to a colleague
▶ Start for $1
Remove trial restrictions
Summary for Patent: 9,441,047
| Title: | Methods for improving asthma symptoms using benralizumab |
| Abstract: | Provided herein are methods of improving asthma symptoms, e.g., as measured by an asthma control questionnaire, comprising administering to the patient an effective amount of benralizumab or an antigen-binding fragment thereof. |
| Inventor(s): | Ward; Christine (Gaithersburg, MD), Roskos; Lorin (Gaithersburg, MD), Wang; Bing (Gaithersburg, MD), Raible; Donald (Berwyn, PA) |
| Assignee: | ASTRAZENECA AB (Sodertaje, SE) |
| Application Number: | 14/454,149 |
| Patent Claims: | see list of patent claims |
Details for Patent 9,441,047
| Applicant | Tradename | Biologic Ingredient | Dosage Form | BLA | Approval Date | Patent No. | Expiredate |
|---|---|---|---|---|---|---|---|
| Astrazeneca Ab | FASENRA | benralizumab | Injection | 761070 | 11/14/2017 | ⤷ Try a Trial | 2033-08-12 |
| Astrazeneca Ab | FASENRA | benralizumab | Injection | 761070 | 10/03/2019 | ⤷ Try a Trial | 2033-08-12 |
| >Applicant | >Tradename | >Biologic Ingredient | >Dosage Form | >BLA | >Approval Date | >Patent No. | >Expiredate |
